Gefarnate
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Overview
Gefarnate is a drug used for the treatment of gastric ulcers.[1]
It also has been proposed for use in the treatment of dry eye syndrome.[2][3]
References
References
- ↑ Ohta Y, Kobayashi T, Imai Y, Inui K, Yoshino J, Nakazawa S (August 2005). “Effect of gefarnate on acute gastric mucosal lesion progression in rats treated with compound 48/80, a mast cell degranulator, in comparison with that of teprenone” ( – Scholar search). Biol. Pharm. Bull. 28 (8): 1424–30. doi:10.1248/bpb.28.1424. PMID 16079487.
- ↑ Peral A, Domínguez-Godínez CO, Carracedo G, Pintor J (April 2008). “Therapeutic targets in dry eye syndrome”. Drug News Perspect. 21 (3): 166–76. PMID 18560615.
- ↑ Gipson IK, Hori Y, Argüeso P (April 2004). “Character of ocular surface mucins and their alteration in dry eye disease”. Ocul Surf. 2 (2): 131–48. doi:10.1016/s1542-0124(12)70149-0. PMID 17216084.
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH